Лумента

Лумента (fingolimod) is an oral medication used in disease-modifying therapy for relapsing forms of multiple sclerosis. This sphingosine 1-phosphate receptor modulator helps reduce relapses and delay disability progression. It is prescribed under medical supervision for adults and certain pediatric patients.

Fingolimod is used to treat relapsing forms of multiple sclerosis (MS) in adults and children aged 10 and older. It belongs to a class of drugs that modulate the immune system to reduce inflammation and damage to the nervous system. Patients often ask, 'What is fingolimod used for?' to understand its role in managing MS symptoms and slowing disease progression.

Fingolimod works by retaining certain white blood cells in the lymph nodes, which reduces their ability to attack the nervous system. This can help decrease the frequency of MS relapses and slow the accumulation of physical disability. Common effects may include changes in heart rate when starting treatment, which is why initial doses are monitored closely.

Fingolimod should be taken exactly as prescribed by a healthcare provider. It is important to discuss your full medical history, especially heart, liver, or eye conditions, before starting this medication. Regular monitoring, including blood tests and eye exams, is often recommended to check for potential side effects or complications.

Fingolimod may interact with other medications, including certain heart rhythm drugs, antidepressants, and immunosuppressants. Combining it with live vaccines or strong CYP450 inhibitors (e.g., ketoconazole) can increase the risk of side effects. Always inform your doctor about all medications, supplements, or herbal products you are using.